Evidence map›Paper›PMID 30201738›Full record

ArticleEMBO molecular medicine2018

Kyle Thompson, Nicole Mai, Monika Oláhová, Filippo Scialó, Luke E Formosa, David A Stroud, Madeleine Garrett, Nichola Z Lax, Fiona M Robertson, Cristina Jou and 15 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in EMBO molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 5 countries.

Kyle ThompsonWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Nicole MaiWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Monika OláhováWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Filippo ScialóInstitute for Cell and Molecular Biosciences, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
Luke E FormosaDepartment of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Vic., Australia.
David A StroudDepartment of Biochemistry and Molecular Biology and The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Vic., Australia.
Madeleine GarrettDepartment of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Vic., Australia.
Nichola Z LaxWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Fiona M RobertsonWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Cristina JouPathology Department, Hospital Sant Joan de Déu, CIBERER, Barcelona, Spain.
Andres NascimentoNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, CIBERER - ISCIII, Barcelona, Spain.
Carlos OrtezNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, CIBERER - ISCIII, Barcelona, Spain.
Cecilia Jimenez-MallebreraNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, CIBERER - ISCIII, Barcelona, Spain.
Steven A HardyWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Langping HeWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Garry K BrownOxford Medical Genetics Laboratories, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Paula MarttinenInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Robert McFarlandWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-8833-2688
Alberto SanzInstitute for Cell and Molecular Biosciences, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
Brendan J BattersbyInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-8136-2753
Penelope E BonnenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Michael T RyanDepartment of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Vic., Australia.
Zofia Ma Chrzanowska-LightowlersWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Robert N LightowlersWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Robert W TaylorWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK robert.taylor@ncl.ac.uk.ORCID 0000-0002-7768-8873
Wellcome Centre for Mitochondrial Research · GBHospital Sant Joan de Déu Barcelona · ESAustralian Regenerative Medicine Institute · AUNewcastle University · GBUniversity of Helsinki · FIBaylor College of Medicine · USChurchill Hospital · GBThe University of Melbourne · AU

Funding

Personalized Functional Genomics for Mitochondrial Encephalopathy Gene DiscoveryR01NS083726 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI BONNEN, PENELOPE E · 2014 to 2025
$6.1M
Biotechnology and Biological Sciences Research Council BB/M023311/1Medical Research Council G0800674NINDS NIH HHS R01 NS083726Wellcome TrustWellcome Trust 203105/Z/16/Z
6 · The paper itself

Abstract

OXA1, the mitochondrial member of the YidC/Alb3/Oxa1 membrane protein insertase family, is required for the assembly of oxidative phosphorylation complexes IV and V in yeast. However, depletion of human OXA1 (OXA1L) was previously reported to impair assembly of complexes I and V only. We report a patient presenting with severe encephalopathy, hypotonia and developmental delay who died at 5 years showing complex IV deficiency in skeletal muscle. Whole exome sequencing identified biallelic

Indexed as

Oxidative PhosphorylationAmino Acid SequenceAnimalsBase SequenceChild, PreschoolDNA, MitochondrialDrosophilaElectron Transport Chain Complex ProteinsElectron Transport Complex IVFatal OutcomeFibroblastsHEK293 CellsHumansInfantMaleMitochondriaDNA, MitochondrialElectron Transport Chain Complex ProteinsElectron Transport Complex IVMitochondrial ProteinsNuclear ProteinsOXA1 proteinencephalopathyinsertasemitochondriaOXA1LOXPHOS

Identifiers

PMID30201738
PMCPMC6220311
OpenAlexW2890084884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.